RESEARCH-USE BIOSIMILAR ANTIBODY
Sofituzumab
Monoclonal antibody · IgG1
Sofituzumab (MMUC 1206A) is an anti-MUC16 antibody with a Kd of 0.3-0.9 nM. Sofituzumab can bind multiple adjacent antibody molecules to the repeat sequences of the same MUC16 molecule. Sofituzumab exhibits no anti-tumor activity in the HPAC pancreatic adenocarcinoma xenograft model.
TARGETMUC16
YMonoclonal antibody
CATALOGSC-BS-153
CATALOG NUMBERSC-BS-153
MOLECULAR WEIGHTApprox. 150 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Sofituzumab (MMUC 1206A) is an anti-MUC16 antibody with a Kd of 0.3-0.9 nM. Sofituzumab can bind multiple adjacent antibody molecules to the repeat sequences of the same MUC16 molecule. Sofituzumab exhibits no anti-tumor activity in the HPAC pancreatic adenocarcinoma xenograft model.
Sofituzumab is a recombinant research-use antibody directed against MUC16.